Quality of life and new antipsychotics in schizophrenia. Are patients better off?
about
Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic diseaseThe Self-Perception and Relationships Tool (S-PRT): a novel approach to the measurement of subjective health-related quality of lifeA new measure of patient satisfaction with ocular hypotensive medications: the Treatment Satisfaction Survey for Intraocular Pressure (TSS-IOP)Quality of life in schizophrenia: a grounded theory approachHow antipsychotics work-from receptors to reality.Preliminary data concerning the reliability and psychometric properties of the Greek translation of the 20-item Subjective Well-Being Under Neuroleptic Treatment Scale (SWN-20)Patient compliance with drug therapy in schizophrenia. Economic and clinical issues.New antipsychotics, compliance, quality of life, and subjective tolerability--are patients better off?Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychoticsCurrent approaches to treatments for schizophrenia spectrum disorders, part II: psychosocial interventions and patient-focused perspectives in psychiatric care.Antipsychotic medication-induced dysphoria: its meaning, association with typical vs. atypical medications and impact on adherence.Perceived efficacy of salbutamol by persons with spinal muscular atrophy: A mixed methods study.Impact of side-effects of atypical antipsychotics on non-compliance, relapse and cost.Second-generation antipsychotics: looking beyond efficacy.Assessing cost-effectiveness of drug interventions for schizophrenia.Promoting discussions and decisions about dogs' quality-of-life.Quality of life in schizophrenia on conventional versus atypical antipsychotic medication: a comparative cross-sectional study.Quality of life assessment in Turkish patients with schizophrenia and their relatives.
P2860
Q24792437-FF6D169A-2FAB-4937-87E0-A0A4D3CE0951Q24796009-6CE11D45-6955-475E-B841-294F80E9D115Q24798313-D1F00060-FF67-4E1D-AE4F-3BD8F18A88ACQ24798321-4357CB0D-46D8-48F8-9D90-146416D1857DQ30457477-7A8AC826-4D78-4AFF-9F0B-B927560B8E09Q33401710-DEC55C46-37C3-48F8-AF43-545C3662EDD8Q34078005-384F0806-8F84-41C8-ABC3-38DF6BBC4A58Q35805896-5076DC34-12FE-4DA6-B698-FF6D0A38C354Q36467615-9D135BF9-1C30-4D80-B81C-981D942824FBQ37221010-8F2DE6B9-46F7-4482-AE75-43B5279E9019Q38244017-D80059DC-4789-4082-B636-C0DAE15ACA51Q39926048-AEE98F29-6EDA-4AD9-ADBC-AB4EBA22D871Q44518077-C99491FD-BD12-4B3A-9459-EA32D3FF2E45Q44937604-821BCCD3-606B-4F24-B740-E6C2C8FD1585Q45231263-E3B01DED-9EE9-4732-86D4-068AEBF281D9Q48597346-8FC71EFE-73B8-40AA-AA03-850B66463D8DQ51915956-DEC56C3A-2591-4D4A-8D5D-CA840BCE0F1EQ53325477-1EA5F9B5-7CD1-44D4-885B-7ED7778737D2
P2860
Quality of life and new antipsychotics in schizophrenia. Are patients better off?
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Quality of life and new antipsychotics in schizophrenia. Are patients better off?
@en
type
label
Quality of life and new antipsychotics in schizophrenia. Are patients better off?
@en
prefLabel
Quality of life and new antipsychotics in schizophrenia. Are patients better off?
@en
P2860
P1476
Quality of life and new antipsychotics in schizophrenia. Are patients better off?
@en
P2093
L N Voruganti
P2860
P304
P356
10.1177/002076409904500405
P577
1999-01-01T00:00:00Z